Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biotinylated Anti-Human CTGF | Login | Biotinylated Anti-Human CTGF | ||||||||||||||||
|
||||||||||||||||||
Anti-Human CTGF | Login | Anti-Human CTGF | ||||||||||||||||
|
||||||||||||||||||
Biotinylated Anti-Human CTGFL/WISP-2 | Login | Biotinylated Anti-Human CTGFL/WISP-2 | ||||||||||||||||
|
||||||||||||||||||
Anti-Human CTGFL/WISP-2 | Login | Anti-Human CTGFL/WISP-2 | ||||||||||||||||
|
||||||||||||||||||
Biotinylated Anti-Human EG-VEGF | Login | Biotinylated Anti-Human EG-VEGF | ||||||||||||||||
|
||||||||||||||||||
Anti-Human EG-VEGF | Login | Anti-Human EG-VEGF | ||||||||||||||||
|
||||||||||||||||||
Biotinylated Anti-Human sFas Ligand | Login | Biotinylated Anti-Human sFas Ligand | ||||||||||||||||
|
||||||||||||||||||
Anti-Human sFas Ligand | Login | Anti-Human sFas Ligand | ||||||||||||||||
|
||||||||||||||||||
Biotinylated Anti-Human sFas Receptor | Login | Biotinylated Anti-Human sFas Receptor | ||||||||||||||||
|
||||||||||||||||||
Anti-Human sFas Receptor | Login | Anti-Human sFas Receptor | ||||||||||||||||
|
||||||||||||||||||
Biotinylated Anti-Human FGF-basic | Login | Biotinylated Anti-Human FGF-basic | ||||||||||||||||
|
||||||||||||||||||
Biotinylated Anti-Human FGF-4 | Login | Biotinylated Anti-Human FGF-4 | ||||||||||||||||
|
||||||||||||||||||
Anti-Human FGF-4 | Login | Anti-Human FGF-4 | ||||||||||||||||
|
||||||||||||||||||
Biotinylated Anti-Human FGF-10 | Login | Biotinylated Anti-Human FGF-10 | ||||||||||||||||
|
||||||||||||||||||
Anti-Human FGF-10 | Login | Anti-Human FGF-10 | ||||||||||||||||
|
||||||||||||||||||
Biotinylated Anti-Human FGF-16 | Login | Biotinylated Anti-Human FGF-16 | ||||||||||||||||
|
||||||||||||||||||
Anti-Human FGF-16 | Login | Anti-Human FGF-16 | ||||||||||||||||
|
||||||||||||||||||
Biotinylated Anti-Human FGF-17 | Login | Biotinylated Anti-Human FGF-17 | ||||||||||||||||
|
||||||||||||||||||
Biotinylated Anti-Human FGF-17 | Login | Biotinylated Anti-Human FGF-17 | ||||||||||||||||
|
||||||||||||||||||
Anti-Human FGF-17 | Login | Anti-Human FGF-17 | ||||||||||||||||
|
||||||||||||||||||
S100A2 Human Protein | Login | S100A2 Human Protein | ||||||||||||||||
|
||||||||||||||||||
S100A5 Human Protein | Login | S100A5 Human Protein | ||||||||||||||||
|
||||||||||||||||||
S100b Mouse Protein | Login | S100b Mouse Protein | ||||||||||||||||
|
||||||||||||||||||
S100G Human Protein | Login | S100G Human Protein | ||||||||||||||||
|
||||||||||||||||||
S100P Human, His Protein | Login | S100P Human, His Protein | ||||||||||||||||
|